Article ID Journal Published Year Pages File Type
6830104 Seizure 2018 12 Pages PDF
Abstract
This first demonstration that an AAV-NPY construct can successfully transduce human neuronal cells supports the pre-clinical development of a clinical trial using AAV-based NPY for pharmacoresistant epilepsy.
Keywords
Related Topics
Life Sciences Neuroscience Behavioral Neuroscience
Preview
A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell line
Authors
, , , , , ,